Shares of Moderna Inc. (NASDAQ: MRNA) were down 3% in morning hours on Thursday despite the company reporting the first profitable quarter
Moderna (MRNA): COVID-19 vaccine helps company deliver first ever profitable quarter
Categories
Health Care
CVS Health gets a shot in the arm from COVID care: Is the stock a buy?
After being hit by the virus-induced slowdown in store footfall initially, CVS Health Corporation (NYSE: CVS) has regained the lost momentum by
Pfizer, Inc. (PFE) Q1 2021 Earnings Call Transcript
Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
CVS Health Corporation (CVS) Q1 2021 Earnings Call Transcript
CVS Health Corporation (NYSE: CVS) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Katie Durant -- Senior Director, Investor Relations Karen S.
Here’s a look at the pros and cons of investing in Cigna (CI)
After a series of ups and downs, shares of healthcare company Cigna Corporation (NYSE: CI) rose to a record high a few
CVS Health Corp. (CVS) Earnings: 1Q21 Key Numbers
VS Health Corporation (NYSE: CVS) reported first-quarter 2021 earnings results today. Total revenues increased 3.5% to $69.1 billion compared to the same
Pfizer (PFE) reports Q1 EPS of 93 cents: Infographic
Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported Q1 revenue
Trxade expects its health passport to be a key post-pandemic reopening tool
Over the past few months, Trxade Group (NASDAQ: MEDS) has been busy in its development lab, creating tools that could enable the
PetMed Express, Inc. (PETS) Q4 2020 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ: PETS) Q4 2020 earnings call dated May. 03, 2021 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its first quarter financial results for the period ended March 31, 2021. Net income for the first
AbbVie (ABBV) Stock: Here’s what you need to know before investing
AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's flagship product
Vertex Pharmaceuticals Inc (VRTX) Q1 2021 Earnings Call Transcript
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations
Biomarin Pharmaceutical Inc. (BMRN) Q1 2021 Earnings Call Transcript
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Traci McCarty -- Vice President of Investor Relations Jean-Jacques
Infographic: Highlights of Gilead Sciences (GILD) Q1 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell. The revenue increased by 16%
Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic
Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported Q1 revenue
Merck & Co., Inc. (MRK) Q1 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Kenneth
Abiomed, Inc. (ABMD) Q4 2021 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q4 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q1 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported first quarter 2021 earnings results today. Revenues increased 3% year-over-year to $11.1 billion. Net earnings attributable
GlaxoSmithKline plc. (GSK) Q1 2021 Earnings Call Transcript
GlaxoSmithKline plc. ( LON: GSK) Q1 2021 earnings call dated Apr. 28, 2021 Corporate Participants: Iain Mackay -- Chief Financial Officer Dame Emma Walmsley -- Chief
Boston Scientific Corp. (BSX) Q1 2021 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q1 2021 earnings call dated Apr. 28, 2021 Corporate Participants: Susie Lisa -- Vice President, Investor Relations Michael F.
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results
Teva Pharmaceuticals’ (NYSE: TEVA) reported first-quarter 2021 results today before the opening bell. The company dropped its revenue by 9% to $3.98